Summit Therapeutics Inc (SMMT)
19.00
+0.58
(+3.15%)
USD |
NASDAQ |
Nov 22, 16:00
19.02
+0.02
(+0.11%)
After-Hours: 20:00
Summit Therapeutics Total Liabilities (Quarterly): 64.93M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 64.93M |
June 30, 2024 | 146.78M |
March 31, 2024 | 132.57M |
December 31, 2023 | 125.26M |
September 30, 2023 | 119.10M |
June 30, 2023 | 117.77M |
March 31, 2023 | 121.42M |
December 31, 2022 | 537.51M |
September 30, 2022 | 22.08M |
June 30, 2022 | 44.40M |
March 31, 2022 | 52.06M |
December 31, 2021 | 30.09M |
September 30, 2021 | 26.38M |
June 30, 2021 | 26.09M |
March 31, 2021 | 76.39M |
December 31, 2020 | 23.04M |
September 30, 2020 | 20.00M |
March 31, 2020 | 21.35M |
October 31, 2019 | 16.11M |
July 31, 2019 | 17.90M |
April 30, 2019 | 19.41M |
January 31, 2019 | 23.74M |
October 31, 2018 | 21.34M |
July 31, 2018 | 18.02M |
April 30, 2018 | 79.81M |
Date | Value |
---|---|
January 31, 2018 | 82.56M |
October 31, 2017 | 43.03M |
July 31, 2017 | 49.50M |
April 30, 2017 | 50.28M |
January 31, 2017 | 51.35M |
October 31, 2016 | 51.12M |
July 31, 2016 | 5.366M |
April 30, 2016 | 5.658M |
January 31, 2016 | 12.78M |
October 31, 2015 | 5.445M |
July 31, 2015 | 5.283M |
April 30, 2015 | 5.278M |
January 31, 2015 | 9.694M |
October 31, 2014 | 5.851M |
July 31, 2014 | 5.747M |
January 31, 2014 | 4.178M |
July 31, 2013 | 2.225M |
January 31, 2013 | 2.410M |
July 31, 2012 | 1.076M |
July 31, 2012 | 1.076M |
January 31, 2012 | 2.340M |
July 31, 2011 | 3.415M |
January 31, 2011 | 2.236M |
July 31, 2010 | 4.585M |
January 31, 2010 | 5.154M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
20.00M
Minimum
Sep 2020
537.51M
Maximum
Dec 2022
94.85M
Average
58.50M
Median
Total Liabilities (Quarterly) Benchmarks
Merck & Co Inc | 72.97B |
Terns Pharmaceuticals Inc | 13.76M |
Instil Bio Inc | 96.23M |
Viking Therapeutics Inc | 26.44M |
Moderna Inc | 3.876B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 502.85M |
Shareholders Equity (Quarterly) | 437.92M |